FOXM1 and neoplasm: Antitumor growth response, which was measured as change in mean tumor weight, indicated an additive effect of the combined FoxM1-shRNA and IR on tumor growth inhibition (vs. FoxM1-shRNA p= 0.002; vs. NC+IR p= 0.009) (Figure 5D).